access to healthcare
MSF welcomes Indian Patent Office’s rejection of J&J’s application for paediatric formulation of lifesaving TB drug
MSF and Health Justice Initiative welcome J&J’s withdrawal of patents on lifesaving TB drug in South Africa
Secrets Cost Lives: Transparency and access to medical products
Danaher continues to charge exorbitant prices for lifesaving medical tests despite urgent demands for price reductions by several Ministries of Health
Lack of hepatitis C care means most Rohingya refugees cannot be cured amid alarming prevalence rates in camps in Bangladesh
Urgent call for Europe to improve treatment access for tuberculosis: Many TB medicines and formulations accessible in lower- and middle-income countries remain unaffordable or unavailable in Europe
Marking 40 years of humanitarian medical action in Mozambique: Médecins Sans Frontières hosts panel discussion in Maputo
Gavi’s next strategy must make sure to reach the 10 million children in fragile and humanitarian settings who are missing vaccines
“Violence, desperation and abandonment on the migration route”: MSF presents its migration report in Mexico and Central America
